HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relationship between oral amiodarone and inappropriate therapy from an implantable cardioverter defibrillator.

AbstractBACKGROUND:
This study evaluated the efficacy of amiodarone for avoiding inappropriate therapies by implantable cardioverter defibrillators (ICDs).
METHODS AND RESULTS:
A total of 232 patients with structural heart disease (58+/-13 years; 78% males) who underwent an initial ICD implantation were retrospectively investigated to compare baseline characteristics and event rates of inappropriate ICD therapy delivery between patients with oral amiodarone therapy (amiodarone group, n=116) and those without (non-amiodarone group, n=116). During a mean follow-up of 29+/-21 months, inappropriate therapies occurred less frequently in the amiodarone group than in the non-amiodarone group (12% vs 27%, P=0.0068). As a cause of inappropriate ICD therapy, only atrial fibrillation (AF) significantly differed between the groups (3% vs 12%, P=0.01). The results of multivariate logistic regression analysis showed that amiodarone therapy (odds ratio (OR) 0.38, 95% confidence interval (CI) 0.19-0.77, P=0.0073) and no history of spontaneous AF (OR 0.27, 95%CI 0.13-0.57, P=0.0007) were independent predictors of a lower risk of inappropriate ICD therapy.
CONCLUSIONS:
In the present group of ICD patients with structural heart disease, inappropriate therapy delivery occurred predominantly in those with spontaneous AF and/or without amiodarone.
AuthorsTakayuki Nagai, Kazuhiro Satomi, Takashi Noda, Hideo Okamura, Yuko Yamada, Wataru Shimizu, Kazuhiro Suyama, Naohiko Aihara, Shiro Kamakura, Takashi Kurita
JournalCirculation journal : official journal of the Japanese Circulation Society (Circ J) Vol. 74 Issue 7 Pg. 1302-7 (Jul 2010) ISSN: 1347-4820 [Electronic] Japan
PMID20484827 (Publication Type: Journal Article)
Chemical References
  • Amiodarone
Topics
  • Aged
  • Amiodarone (administration & dosage)
  • Atrial Fibrillation
  • Defibrillators, Implantable (adverse effects)
  • Female
  • Heart Diseases (therapy)
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Risk Factors
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: